Market revenue in 2023 | USD 217.2 million |
Market revenue in 2030 | USD 356.0 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 69.15% in 2023. Horizon Databook has segmented the U.S. bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of lung cancer in the U.S. is a significant factor driving market growth. According to the American Cancer Society, the number of new lung cancer cases is projected to rise, necessitating more frequent diagnostic procedures, including bronchial biopsies.
This trend underscores the need for effective biopsy devices to facilitate timely diagnosis and treatment. According to data from the Lung Cancer Research Foundation, 1 in 16 people in the U.S. will be diagnosed with lung cancer during their lifetime. In addition, around 238,340 individuals were diagnosed with lung cancer in 2023.
The rising prevalence of COPD and interstitial lung diseases is another factor expected to drive the demand for bronchial biopsy devices. As of May 2024, the CDC reported that over 14 million Americans have COPD. According to data published in a Springer Link article, in May 2023, over 500,000 bronchoscopies are performed annually, with around 15% of these procedures including bronchial biopsies.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account